Core Scientific (CORZ) Stock Price Drops As AI Pivot Meets $1.08b Loss

Core Scientific entered this earnings report with a high growth story and a stock that had already been under pressure over the past month. The market’s initial reaction was clear, with the share price falling 12.65% to US$18.12 in regular trading after the results.

The main headline is not revenue, which came in at US$164.2 million for the quarter. The focus is on the size of the loss. Core Scientific reported net income from ongoing operations excluding extra items of US$1.08b in the red and basic earnings per share of US$3.32 in the red, placing the balance sheet and funding plan firmly in the spotlight for investors.

Concerned by Core Scientific's steep reported loss and looking for stocks with stronger financial footing alongside growth potential? Take a look at our list of solid balance sheet and fundamentals stocks (48 results)

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$164.2 million vs. US$78.6 million (more than doubled year on year)
• Net Loss, Excluding Extra Items (Q2 2026 vs. Q2 2025): loss of US$1.081b vs. loss of US$13.3 million (very large year on year deterioration)
• Basic EPS (Q2 2026 vs. Q2 2025): loss of US$3.32 per share vs. loss of US$0.04 per share (loss per share widened sharply)
• Trailing 12 Month Revenue (Q2 2026 vs. Q2 2025): US$440.3 million vs. US$348.4 million (higher revenue over the past year)

Tired of scrolling through dense earnings reports and trying to make sense of Core Scientific’s figures line by line? Get a clear, visual view of the company’s financial health and balance sheet strength in our company report for Core Scientific.

Core Scientific’s AI Pivot Hits Key Contract Milestones

Bulls argue Core Scientific is becoming an AI infrastructure and colocation platform with long term, contract backed revenue rather than a volatile bitcoin miner. The latest quarter gives solid proof points on that shift. Colocation revenue of US$137 million in Q2 now represents most of the US$164.2 million total, supported by about 1.1 GW of contracted billable capacity and more than US$24b of base contracted revenue.

The new 15 year AMD partnership for up to 2.5 GW, with an initial 530 MW and 2.5% annual escalators, reinforces the idea of multi year, power dense deals with high quality counterparties. About 437 MW is already billing as of mid July, which shows that Core Scientific is not just signing contracts but converting them into live, invoiced capacity. The bitcoin mining wind down, with fewer miners online and activity focused on offsetting power costs, further supports the narrative that hosting is taking over as the primary engine.

Compare this push toward long term, contract backed AI infrastructure revenue with how the recent 12.65% share price drop might be shaping sentiment on Wall Street. See the consensus price target analysis for Core Scientific to check whether analyst targets reflect confidence in Core Scientific’s pivot or more caution around the risks.

Core Scientific Bears Focus On Losses And Execution Risk

The bearish view on Core Scientific centers on heavy reliance on a few long term AI hosting contracts and the strain of funding the build out. This quarter gives those critics fresh talking points. Revenue reached US$164.2 million, yet the company reported a net loss from ongoing operations of about US$1.08b with a loss of US$3.32 per share. That is a very deep loss for a quarter where 437 MW only started billing in mid July and most AMD related capacity does not begin contributing until 2027.

Bears also worry that capital intensity and timing gaps will weigh on returns. Management flagged around US$6b of capex for the initial 530 MW AMD commitment versus roughly US$1.8b of liquidity. The recent 12.65% one day share price drop and roughly 30% decline over 30 days suggest investors are treating the loss and funding bridge as milestones not yet cleared.

After a quarterly loss of about US$1.08b and less than one year of cash runway, it is worth asking whether these funding pressures and contract commitments are isolated growing pains or signs of deeper financial fragility. Review our risk analysis for Core Scientific which shows 2 important warning signs

Take Control Of Your Next Move

If Core Scientific’s sharp quarterly loss and AI hosting pivot have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how sentiment develops. After you decide to take a position, keep your focus with the Portfolio Command Center that filters out noise and surfaces only the key developments that matter for your holdings. For a broader view on Core Scientific and similar stocks, tap into the shared insights inside the Community to see how other investors are reacting to new data. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond Core Scientific?

Fresh stock ideas can move from quiet accumulation to full breakout before most investors react. Use these curated picks while they remain under the radar for now and get in early.

• Spot early momentum shifts in resilient companies by scanning a curated 85 resilient stocks with low risk scores that keeps volatility in check while you focus on potential upside.
• Hunt for powerful cash flow stories using a hand picked 48 high quality undervalued stocks set that may still trade below what their balance sheets and profits suggest.
• Ride the AI build out wave through carefully filtered 56 AI infrastructure stocks that sit behind the data centers and power hungry workloads others only talk about.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com